Literature DB >> 8756390

The National Cancer Data Base. Report on colon cancer.

J M Jessup1, L S McGinnis, G D Steele, H R Menck, D P Winchester.   

Abstract

BACKGROUND: Commission on Cancer data from the National Cancer Data Base (NCDB) report time trends in stage of disease, treatment patterns, and survival for patients with selected cancers. The most current data (1993) for patients with colon cancer are described.
METHODS: Five calls for data yielded 3,700,000 cases of cancer for the years 1985 through 1993 from hospital cancer registeries across the U.S., including 36,937 cases of colon cancer from 1988 and 44,812 from 1993.
RESULTS: Interesting trends are as follows: (1) the elderly ( > 80 years) present with earlier stage disease than younger patients; (2) the National Cancer Institute recognized cancer centers have more patients with advanced disease than other types of hospitals; (3) all ethnic groups have generally similar stages of disease at presentation, except for African-Americans who have a slightly higher incidence of Stage IV disease; (4) the proximal migration of the primary cancer continues with 54.7% of primary colon cancer arising in the right colon in 1993 compared with 50.9% in 1988; (5) an interaction between grade and stage of cancer seems present; and (6) patients with Stage III colon cancer who received adjuvant chemotherapy had a 5% improvement in 5-year relative survival.
CONCLUSIONS: The NCDB data are useful for reporting what cancer treatments are being administered and what outcomes are occurring in the U.S. The data suggest an important biologic role for grade of cancer. They also suggest that African-Americans and other ethnic groups have the same outcome as non-Hispanic whites but that access to medical care may still be less. Finally, the utility of adjuvant therapy for Stage III colon cancer may just be beginning to be appreciated.

Entities:  

Mesh:

Year:  1996        PMID: 8756390     DOI: 10.1002/(SICI)1097-0142(19960815)78:4<918::AID-CNCR32>3.0.CO;2-W

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  51 in total

1.  Long-term results of radiofrequency ablation for unresectable colorectal liver metastases: a potentially curative intervention.

Authors:  A A J M Van Tilborg; M R Meijerink; C Sietses; J H T M Van Waesberghe; M O Mackintosh; S Meijer; C Van Kuijk; P Van Den Tol
Journal:  Br J Radiol       Date:  2010-12-15       Impact factor: 3.039

2.  Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer.

Authors:  Andrew T Chan; Edward L Giovannucci; Jeffrey A Meyerhardt; Eva S Schernhammer; Gary C Curhan; Charles S Fuchs
Journal:  JAMA       Date:  2005-08-24       Impact factor: 56.272

3.  Colonoscopy screening in African Americans and Whites with affected first-degree relatives.

Authors:  Harvey J Murff; Neeraja B Peterson; Jay H Fowke; Margaret Hargreaves; Lisa B Signorello; Robert S Dittus; Wei Zheng; William J Blot
Journal:  Arch Intern Med       Date:  2008-03-24

4.  The role of adjuvant chemotherapy in stage II colorectal cancer patients.

Authors:  Hung-Hsin Lin; Yu-Yao Chang; Jen-Kou Lin; Jeng-Kai Jiang; Chun-Chi Lin; Yuan-Tzu Lan; Shung-Haur Yang; Huann-Sheng Wang; Wei-Shone Chen; Tzu-Chen Lin; Shih-Ching Chang
Journal:  Int J Colorectal Dis       Date:  2014-07-15       Impact factor: 2.571

5.  Increasing Disparity in Colorectal Cancer Incidence and Mortality Among African Americans and Whites: A State's Experience.

Authors:  Noelle K Loconte; Amy Williamson; Arlene Gayle; Jennifer Weiss; Ticiana Leal; Jeremy Cetnar; Tabraiz Mohammed; Amye Tevaarwerk; Nathan Jones
Journal:  J Gastrointest Oncol       Date:  2011

6.  Is adjuvant chemotherapy beneficial to high risk stage II colon cancer? Analysis in a single institute.

Authors:  Chun-Chi Lin; Jen-Kou Lin; Shih-Ching Chang; Huann-Sheng Wang; Shung-Haur Yang; Jeng-Kai Jiang; Wei-Shone Chen; Tzu-Chen Lin
Journal:  Int J Colorectal Dis       Date:  2009-02-24       Impact factor: 2.571

7.  Laparoscopic colectomy for colon cancer: comparable to conventional oncologic surgery?

Authors:  Ricardo M Bonnor; Kirk A Ludwig
Journal:  Clin Colon Rectal Surg       Date:  2005-08

8.  Management of hepatic metastases from colorectal cancer.

Authors:  Ketan R Sheth; Bryan M Clary
Journal:  Clin Colon Rectal Surg       Date:  2005-08

9.  Therapeutic molecular targeting of 15-lipoxygenase-1 in colon cancer.

Authors:  Yuanqing Wu; Bingliang Fang; Xiulan Q Yang; Li Wang; Dongning Chen; Victor Krasnykh; Bing Z Carter; Jeffrey S Morris; Imad Shureiqi
Journal:  Mol Ther       Date:  2008-03-18       Impact factor: 11.454

10.  Anticancer Chemotherapy and it's Anaesthetic Implications (Current Concepts).

Authors:  R P Gehdoo
Journal:  Indian J Anaesth       Date:  2009-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.